BRIEF published on 09/04/2026 at 14:55, 13 days 6 hours ago DBV Technologies: Threshold Movements by JP Morgan Chase & Co. Threshold Crossing DBV Technologies JP Morgan Chase Capital Participation Statement Of Intent
BRIEF published on 09/03/2026 at 22:37, 13 days 22 hours ago DBV Technologies is participating in investor conferences in September New York Investor Conferences Investment Biopharmaceutical DBV Technologies
BRIEF published on 09/03/2026 at 22:37, 13 days 22 hours ago DBV Technologies to Engage in September Investor Conferences New York Investor Conferences Biopharmaceutical Fireside Chat DBV Technologies
PRESS RELEASE published on 09/03/2026 at 22:32, 13 days 22 hours ago DBV Technologies to Participate in Upcoming September Investor Conferences DBV Technologies announces participation in upcoming investor conferences in September 2026, focusing on biopharmaceutical developments for food allergies and immunologic conditions Investor Conferences Biopharmaceutical DBV Technologies Food Allergies Immunologic Conditions
BRIEF published on 09/03/2026 at 00:00, 14 days 21 hours ago DBV Technologies: Status of Voting Rights as of August 31, 2026 Share Capital Voting Rights DBV Technologies NYSE Euronext Paris 2026
BRIEF published on 09/03/2026 at 00:00, 14 days 21 hours ago DBV Technologies Announces Share and Voting Rights Data as of August 2026 Voting Rights Shares Financial Disclosure DBV Technologies NYSE Euronext Paris
PRESS RELEASE published on 09/02/2026 at 23:55, 14 days 21 hours ago Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026 Company discloses total number of voting rights and shares as of August 31, 2026 in accordance with AMF regulations Voting Rights Shares AMF Regulations NYSE Euronext Paris Total Number
BRIEF published on 08/25/2026 at 10:26, 23 days 10 hours ago DBV Technologies: Thresholds crossed by JP Morgan Crossing Thresholds DBV Technologies JP Morgan Chase Capital And Voting Rights Shares By Analogy
BRIEF published on 08/17/2026 at 13:43, 1 month ago Threshold crossings: JP Morgan Chase & Co. and DBV Technologies Share Capital Voting Rights Threshold Crossing DBV Technologies JP Morgan Chase & Co.
BRIEF published on 07/30/2026 at 23:45, 1 month 17 days ago DBV Technologies raises $50 million through ADS issuance Nasdaq American Depositary Shares DBV Technologies At-the-Market RA Capital Management
Published on 09/17/2026 at 15:55, 5 hours 15 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 5 hours 45 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 6 hours 10 minutes ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 6 hours 10 minutes ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 6 hours 20 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 19:00, 2 hours 9 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 2 hours 11 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 2 hours 44 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 2 hours 59 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 3 hours 23 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 3 hours 30 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 3 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 14 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
